BioCentury
ARTICLE | Company News

AdnaGen, OncoVista Inc. deal

December 24, 2007 8:00 AM UTC

AVUG increased its stake in AdnaGen to 85% from 51% for an undisclosed amount. AVUG acquired a majority stake in the company last year (see BioCentury, Feb. 27, 2006). AdnaGen markets the AdnaTest Br...